当前位置： SCI文献检索 > EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING期刊下所有文献 > The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.

The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.

Abstract：

PURPOSE:Our aim was to assess the prognostic and predictive value of somatostatin receptor 2 (sstr2) in neuroendocrine tumors (NETs). METHODS:We established a tissue microarray and imaging database from NET patients that received sstr2-targeted radiopeptide therapy with yttrium-90-DOTATOC, lutetium-177-DOTATOC or alternative treatment. We used univariate and multivariate analyses to identify prognostic and predictive markers for overall survival, including sstr2-imaging and sstr2-immunohistochemistry. RESULTS:We included a total of 279 patients. In these patients, sstr2-immunohistochemistry was an independent prognostic marker for overall survival (HR: 0.82, 95 % CI: 0.67 - 0.99, n = 279, p = 0.037). In DOTATOC patients, sstr2-expression on immunohistochemistry correlated with tumor uptake on sstr2-imaging (n = 170, p < 0.001); however, sstr2-imaging showed a higher prognostic accuracy (positive predictive value: +27 %, 95 % CI: 3 - 56 %, p = 0.025). Sstr2-expression did not predict a benefit of DOTATOC over alternative treatment (p = 0.93). CONCLUSIONS:Our results suggest sstr2 as an independent prognostic marker in NETs. Sstr2-immunohistochemistry correlates with sstr2-imaging; however, sstr2-imaging is more accurate for determining the individual prognosis.

journal_name

Eur J Nucl Med Mol Imaging

journal_title

European journal of nuclear medicine and molecular imaging

authors

Brunner P,Jörg AC,Glatz K,Bubendorf L,Radojewski P,Umlauft M,Marincek N,Spanjol PM,Krause T,Dumont RA,Maecke HR,Müller-Brand J,Briel M,Schmitt A,Perren A,Walter MA

doi

10.1007/s00259-016-3486-2

subject

Has Abstract

pub_date

2017-03-01 00:00:00

pages

468-475

issue

3

eissn

1619-7070

issn

1619-7089

pii

10.1007/s00259-016-3486-2

journal_volume

44

pub_type

杂志文章

相关文献

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING文献大全
  • In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.

    abstract：PURPOSE:Imaging the 18-kDa translocator protein (TSPO) is considered a potential tool for in vivo evaluation of microglial activation and neuroinflammation in the early stages of Alzheimer's disease (AD). ((R)-1-(2-chlorophenyl)-N-[(11)C]-methyl-N-(1-methylpropyl)-3-isoquinoline caboxamide ([(11)C]-(R)-PK11195) has bee...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-013-2359-1

    authors： Varrone A,Mattsson P,Forsberg A,Takano A,Nag S,Gulyás B,Borg J,Boellaard R,Al-Tawil N,Eriksdotter M,Zimmermann T,Schultze-Mosgau M,Thiele A,Hoffmann A,Lammertsma AA,Halldin C

    更新日期：2013-06-01 00:00:00

  • Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.

    abstract：PURPOSE:To develop a computer-assisted automated diagnostic system to distinguish among Alzheimer disease (AD), dementia with Lewy bodies (DLB), and other degenerative disorders in patients with mild dementia. METHODS:Single photon emission computed tomography (SPECT) images with injection of N-Isopropyl-p-[(123)I]iod...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-008-1051-3

    authors： Ishii K,Kanda T,Uemura T,Miyamoto N,Yoshikawa T,Shimada K,Ohkawa S,Minoshima S

    更新日期：2009-05-01 00:00:00

  • Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.

    abstract：PURPOSE:To determine whether the relative metabolic activity of pelvic or para-aortic LN compared with that of primary tumor measured by preoperative [18F]FDG PET/CT scan has prognostic value in patients with endometrioid endometrial carcinoma. METHODS:We retrospectively reviewed patients with endometrioid endometrial...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3805-2

    authors： Chung HH,Cheon GJ,Kim JW,Park NH,Song YS

    更新日期：2018-01-01 00:00:00

  • Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects.

    abstract：:The biodistribution of radioactivity after the administration of a new tracer for alpha4beta2 nicotinic acetylcholine receptors (nAChRs), [123I]5-iodo-3-[2(S)-2-azetidinylmethoxy]pyridine (5-I-A-85380), was studied in ten healthy human subjects. Following administration of 98+/-6 MBq [123I]5-I-A-85380, serial whole-bo...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-001-0695-z

    authors： Fujita M,Seibyl JP,Vaupel DB,Tamagnan G,Early M,Zoghbi SS,Baldwin RM,Horti AG,KoreN AO,Mukhin AG,Khan S,Bozkurt A,Kimes AS,London ED,Innis RB

    更新日期：2002-02-01 00:00:00

  • 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.

    abstract：PURPOSE:Focal congenital hyperinsulinism (CHI) is curable by surgery, which is why identification of the focal lesion is crucial. We aimed to determine the use of 18F-fluoro-dihydroxyphenylalanine (18F-DOPA) PET/CT vs. 68Ga-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic-acid-1-Nal3-octreotide (68Ga-DOTANOC) PET/CT...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3867-1

    authors： Christiansen CD,Petersen H,Nielsen AL,Detlefsen S,Brusgaard K,Rasmussen L,Melikyan M,Ekström K,Globa E,Rasmussen AH,Hovendal C,Christesen HT

    更新日期：2018-02-01 00:00:00

  • Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.

    abstract：PURPOSE:Quantitative image reconstruction in positron emission tomography (PET) requires an accurate attenuation map of the object under study for the purpose of attenuation correction. Current dual-modality PET/CT systems offer significant advantages over stand-alone PET, including decreased overall scanning time and ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-006-0086-6

    authors： Ay MR,Zaidi H

    更新日期：2006-11-01 00:00:00

  • PET and SPET tracers for mapping the cardiac nervous system.

    abstract：:The human cardiac nervous system consists of a sympathetic and a parasympathetic branch with (-)-norepinephrine and acetylcholine as the respective endogenous neurotransmitters. Dysfunction of the cardiac nervous system is implicated in various types of cardiac disease, such as heart failure, myocardial infarction and...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s002590100640

    authors： Langer O,Halldin C

    更新日期：2002-03-01 00:00:00

  • Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

    abstract：PURPOSE:This study aimed at identifying prior therapy dosimetric parameters using 99mTc-labeled macro-aggregates of albumin (MAA) that are associated with contralateral hepatic hypertrophy occurring after unilobar radioembolization of hepatocellular carcinoma (HCC) performed with 90Y-loaded glass microspheres. METHODS...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3845-7

    authors： Palard X,Edeline J,Rolland Y,Le Sourd S,Pracht M,Laffont S,Lenoir L,Boudjema K,Ugen T,Brun V,Mesbah H,Haumont LA,Loyer P,Garin E

    更新日期：2018-03-01 00:00:00

  • Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

    abstract：BACKGROUND:Bone metastases are responsible for most of the morbidity associated with hormone-refractory prostate cancer (HRPC). 153Sm-ethylenediaminetetramethylene phosphonate (153Sm-EDTMP) has been approved for palliation of painful skeletal metastases. We retrospectively investigated the possible synergistic effect o...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-006-0343-8

    authors： Ricci S,Boni G,Pastina I,Genovesi D,Cianci C,Chiacchio S,Orlandini C,Grosso M,Alsharif A,Chioni A,Di Donato S,Francesca F,Selli C,Rubello D,Mariani G

    更新日期：2007-07-01 00:00:00

  • [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.

    abstract：UNLABELLED:The aim of this study was to evaluate the feasibility of using [(18)F] 3'-deoxy-3'-fluorothymidine (FLT) positron emission tomography (PET) for the diagnosis and grading of brain tumors. METHODS:The patient population comprised 26 patients (15 males, 11 females) with brain tumors (n=18) or nontumorous lesio...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-004-1742-3

    authors： Choi SJ,Kim JS,Kim JH,Oh SJ,Lee JG,Kim CJ,Ra YS,Yeo JS,Ryu JS,Moon DH

    更新日期：2005-06-01 00:00:00

  • An imaging co-registration system using novel non-invasive and non-radioactive external markers.

    abstract：:We present a system of image co-registration and its validation in phantom and volunteer studies. The system co-registered images via six novel non-invasive and non-radioactive external markers. The fiducial markers were attached with sponge bases on the skin surface of the phantom and the volunteers in a non-collinea...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-003-1173-6

    authors： Wu TH,Wang JK,Lee JJ,Liu RS,Guo WY

    更新日期：2003-06-01 00:00:00

  • Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.

    abstract：PURPOSE:The aim of this study was to investigate metabolic and textural parameters from pretreatment [(18)F]FDG PET/CT scans for the prediction of neoadjuvant radiation chemotherapy response and 3-year disease-free survival (DFS) in patients with locally advanced rectal cancer (LARC). METHODS:We performed a retrospect...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-015-3180-9

    authors： Bang JI,Ha S,Kang SB,Lee KW,Lee HS,Kim JS,Oh HK,Lee HY,Kim SE

    更新日期：2016-03-01 00:00:00

  • Global and segmental absolute stress myocardial blood flow in prediction of cardiac events: [15O] water positron emission tomography study.

    abstract：PURPOSE:We evaluated the value of reduced global and segmental absolute stress myocardial blood flow (sMBF) quantified by [15O] water positron emission tomography (PET) for predicting cardiac events in patients with suspected obstructive coronary artery disease (CAD). METHODS:Global and segmental sMBF during adenosine...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-05093-2

    authors： Harjulahti E,Maaniitty T,Nammas W,Stenström I,Biancari F,Bax JJ,Knuuti J,Saraste A

    更新日期：2020-11-11 00:00:00

  • Model-based comparison of maternal and foetal organ doses from (99m)Tc pertechnetate, DMSA, DTPA, HDP, MAA and MAG(3) diagnostic intakes during pregnancy.

    abstract：:Organ residence times were calculated for diagnostic intakes of (99m)Tc pertechnetate, 2,3-dimercaptosuccinic acid (DMSA), diethylene triamine penta-acetic acid (DTPA), hydroxymethylene diphosphonate (HDP), macroaggregated albumin (MAA) and mercapto-acetyltriglycine (MAG(3)) during the 1st and 3rd stages of pregnancy ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-002-0858-6

    authors： Saunders M,Palmer M,Preece A,Millard R

    更新日期：2002-10-01 00:00:00

  • Correlation between combining 18F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer.

    abstract：PURPOSE:Our study intended to explore the association between combining 18F-FDG PET/CT metabolic parameters and other clinical features and anaplastic lymphoma kinase (ALK) or c-ros oncogene 1 (ROS1) fusion in non-small-cell lung cancer (NSCLC). METHODS:Eight hundred and six patients with wild-type epidermal growth fa...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04652-6

    authors： Ruan M,Liu L,Wang L,Lei B,Sun X,Chang C,Shen Y,Xie W

    更新日期：2020-05-01 00:00:00

  • [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.

    abstract：PURPOSE:To evaluate the diagnostic potential of PET/MRI with [(18)F]FDG in recurrent ovarian and cervical cancer in comparison to PET/CT. METHODS:A group of 19 patients with suspected recurrence of pelvic malignancies (ovarian cancer, 11 patients; cervical cancer, 8 patients) scheduled for an [(18)F]FDG PET/CT were su...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-014-2902-8

    authors： Beiderwellen K,Grueneisen J,Ruhlmann V,Buderath P,Aktas B,Heusch P,Kraff O,Forsting M,Lauenstein TC,Umutlu L

    更新日期：2015-01-01 00:00:00

  • Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

    abstract：PURPOSE:The purpose of this study was to evaluate therapeutic response to neoadjuvant chemotherapy (NAC) and predict breast cancer recurrence using Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST). MATERIALS AND METHODS:Fifty-nine breast cancer patients underwent fluorodeoxyglucose-positron emi...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00259-018-4008-1

    authors： Kitajima K,Nakatani K,Yamaguchi K,Nakajo M,Tani A,Ishibashi M,Hosoya K,Morita T,Kinoshita T,Kaida H,Miyoshi Y

    更新日期：2018-09-01 00:00:00

  • Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.

    abstract：:Paragangliomas or glomus tumours of the head and neck region are rare somatostatin receptor-expressing neuroendocrine tumours. Precise preoperative diagnosis is of special importance in order to adequately weigh the potential benefit of the operation against the inherent risks of the procedure. In this study, the clin...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-002-0939-6

    authors： Schmidt M,Fischer E,Dietlein M,Michel O,Weber K,Moka D,Stennert E,Schicha H

    更新日期：2002-12-01 00:00:00

  • Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications.

    abstract：:Techniques from the field of artificial intelligence, and more specifically machine (deep) learning methods, have been core components of most recent developments in the field of medical imaging. They are already being exploited or are being considered to tackle most tasks, including image reconstruction, processing (...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-019-04373-w

    authors： Visvikis D,Cheze Le Rest C,Jaouen V,Hatt M

    更新日期：2019-12-01 00:00:00

  • 68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

    abstract：OBJECTIVES:The primary objective was the evaluation of Gallium 68 (68Ga)-prostate-specific membrane antigen (PSMA)-11 positron emission tomography/computed tomography (PET/CT) detection rate, for identifying the site of prostate cancer (PCa) relapse (local vs systemic), stratifying the population according to different...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-018-4189-7

    authors： Ceci F,Castellucci P,Graziani T,Farolfi A,Fonti C,Lodi F,Fanti S

    更新日期：2019-01-01 00:00:00

  • Comparison of bifunctional chelates for (64)Cu antibody imaging.

    abstract：PURPOSE:Improved bifunctional chelates (BFCs) are needed to facilitate efficient (64)Cu radiolabeling of monoclonal antibodies (mAbs) under mild conditions and to yield stable, target-specific agents. The utility of two novel BFCs, 1-Oxa-4,7,10-triazacyclododecane-5-S-(4-isothiocyanatobenzyl)-4,7,10-triacetic acid (p-S...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-010-1506-1

    authors： Ferreira CL,Yapp DT,Crisp S,Sutherland BW,Ng SS,Gleave M,Bensimon C,Jurek P,Kiefer GE

    更新日期：2010-11-01 00:00:00

  • Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients.

    abstract：PURPOSE:To evaluate the clinical value of 68Ga-PSMA PET/CT negativity in patients with biochemical recurrent prostate cancer (BCR). METHODS:One hundred three BCR patients (median age, 70 years; median PSA, 0.47 ng/mL) with negative 68Ga-PSMA PET/CT, followed up for at least 1 year, were retrospectively identified in a...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-04914-8

    authors： Celli M,De Giorgi U,Caroli P,Di Iorio V,Fantini L,Rossetti V,Foca F,Nicolini S,Giganti M,Paganelli G,Matteucci F

    更新日期：2021-01-01 00:00:00

  • Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.

    abstract：RATIONALE:In Parkinson's disease (PD), spatial covariance analysis of 18F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual subjects. We provide a f...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04570-7

    authors： Meles SK,Renken RJ,Pagani M,Teune LK,Arnaldi D,Morbelli S,Nobili F,van Laar T,Obeso JA,Rodríguez-Oroz MC,Leenders KL

    更新日期：2020-02-01 00:00:00

  • Highlights of the European Association of Nuclear Medicine Congress, Athens, Greece, 30 September to 4 October 2006.

    abstract：:The 2006 EANM Congress, held in Athens, Greece, was once again a major event in the nuclear medicine scientific and educational calendar. The scientific programme, which included the second biennial ISRTRD meeting, confirmed the major developments taking place in (1) the diagnostic and prognostic uses of nuclear medic...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type：

    doi：10.1007/s00259-006-0327-8

    authors： McKillop JH,Martin-Comin J,Knapp FF Jr,Britten AJ

    更新日期：2007-02-01 00:00:00

  • TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

    abstract：OBJECTIVE:The 18-kDa mitochondrial translocator protein (TSPO) was reported to be upregulated in gliomas. 18F-GE-180 is a novel 3rd generation TSPO receptor ligand with improved target-to-background contrast compared to previous tracers. In this pilot study, we compared PET imaging with 18F-GE-180 and MRI of patients w...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3799-9

    authors： Albert NL,Unterrainer M,Fleischmann DF,Lindner S,Vettermann F,Brunegraf A,Vomacka L,Brendel M,Wenter V,Wetzel C,Rupprecht R,Tonn JC,Belka C,Bartenstein P,Niyazi M

    更新日期：2017-12-01 00:00:00

  • The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition.

    abstract：UNLABELLED:There are specific dose recommendations for diagnostic amyloid PET imaging with 18F-florbetapir, but they may not apply to research studies using regional quantitative analysis. We, therefore, studied the effect of tracer dose reduction on the discriminative power of regional analysis. METHODS:Using bootstr...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-014-2842-3

    authors： Herholz K,Evans R,Anton-Rodriguez J,Hinz R,Matthews JC

    更新日期：2014-11-01 00:00:00

  • Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.

    abstract：PURPOSE:Brain serotonin 6 receptor (5-HT6) is one of the most recently identified serotonin receptors. It is a potent therapeutic target for psychiatric and neurological diseases, e.g. schizophrenia and Alzheimer's disease. Since no specific fluorinated radioligand has yet been successfully used to study this receptor ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-014-2936-y

    authors： Becker G,Colomb J,Sgambato-Faure V,Tremblay L,Billard T,Zimmer L

    更新日期：2015-03-01 00:00:00

  • Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.

    abstract：PURPOSE:Although two norepinephrine transporter (NET) radioligands, (S,S)-[(18)F]FMeNER-D(2) and (S,S)-[(11)C]MeNER, have been reported to have different characteristics, there has not been a direct comparative study in vivo. METHODS:In this preliminary study, two rhesus monkeys underwent three PET measurements each, ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-009-1194-x

    authors： Takano A,Gulyás B,Varrone A,Halldin C

    更新日期：2009-11-01 00:00:00

  • Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

    abstract：PURPOSE:To evaluate the predictive value of early and late residual (18)F-fluorodeoxyglucose (FDG) and (18)F-fluorothymidine (FLT) uptake using different SUV measurements in PET in patients with advanced non-small-cell lung cancer (NSCLC) treated with erlotinib. METHODS:We retrospectively reviewed data from 30 patient...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-012-2118-8

    authors： Kobe C,Scheffler M,Holstein A,Zander T,Nogova L,Lammertsma AA,Boellaard R,Neumaier B,Ullrich RT,Dietlein M,Wolf J,Kahraman D

    更新日期：2012-07-01 00:00:00

  • Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment.

    abstract：BACKGROUND:The aim of this study was to assess radiomics features on pre-treatment [18F]FDG positron emission tomography (PET) as potential biomarkers for response and survival in patients with metastatic colorectal cancer (mCRC). METHODS:Patients with mCRC underwent [18F]FDG PET/computed tomography (CT) prior to firs...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-018-4100-6

    authors： van Helden EJ,Vacher YJL,van Wieringen WN,van Velden FHP,Verheul HMW,Hoekstra OS,Boellaard R,Menke-van der Houven van Oordt CW

    更新日期：2018-12-01 00:00:00